s20098 has been researched along with Glaucoma, Suspect in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abd-Elsalam, WH; ElKasabgy, NA | 1 |
| Gatto, V; Pescosolido, N; Rusciano, D; Stefanucci, A | 1 |
| Bergua, A; Fonseca, B; Martínez-Águila, A; Pintor, J | 1 |
3 other study(ies) available for s20098 and Glaucoma, Suspect
| Article | Year |
|---|---|
Mucoadhesive olaminosomes: A novel prolonged release nanocarrier of agomelatine for the treatment of ocular hypertension.
Topics: Acetamides; Adhesives; Administration, Ophthalmic; Amines; Animals; Biological Availability; Chemistry, Pharmaceutical; Chitosan; Drug Carriers; Drug Delivery Systems; Drug Liberation; Hexoses; Intraocular Pressure; Male; Ocular Hypertension; Oleic Acid; Particle Size; Rabbits; Solubility | 2019 |
Oral treatment with the melatonin agonist agomelatine lowers the intraocular pressure of glaucoma patients.
Topics: Acetamides; Administration, Oral; Aged; Antihypertensive Agents; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Melatonin; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Pilot Projects; Prospective Studies | 2015 |
Melatonin analogue agomelatine reduces rabbit's intraocular pressure in normotensive and hypertensive conditions.
Topics: Acetamides; Animals; Dose-Response Relationship, Drug; Intraocular Pressure; Melatonin; Ocular Hypertension; Rabbits | 2013 |